Herbal granules plus HIV treatment for low CD4 counts
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether adding a Chinese herbal medicine (Fuyang Jiedu granules) to standard HIV treatment can help raise CD4 cell counts in people whose immune system hasn't recovered well. It may offer a new option for those with persistently low CD4 counts despite years of effective HIV therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been on HIV treatment for more than 4 years.
- Your viral load has been undetectable for over 3 years.
- Your CD4 count is still below 350 cells/uL.
- You have a diagnosis of spleen-kidney yang deficiency according to Traditional Chinese Medicine.
- You are not pregnant, not planning pregnancy, and not taking immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a traditional Chinese herbal medicine (Qiling Yiqi tablets) to standard HIV treatment can help raise CD4+ T-cell counts in people whose immune systems haven't fully recovered. It may offer a new option for those with persistently low counts despite effective viral suppression.
This study tests a new drug, GS-0415, for people with HIV. The study will see if this drug can help control the virus. Participants will continue taking their regular HIV medication.
This study tests new treatments to help people with HIV who have low CD4 counts despite antiretroviral therapy. It aims to improve immune function and reduce the risk of infections.
This study tests an experimental drug called JL18008 in people with HIV who have been on stable HIV medications for years but whose immune systems (CD4 cells) haven't recovered as expected. The drug may help boost immune function in these patients.
This trial tests a Chinese herbal formula (YSQTG) combined with standard immunotherapy and chemotherapy for people newly diagnosed with extensive-stage small cell lung cancer. The goal is to see if adding YSQTG improves outcomes for patients with a specific traditional Chinese medicine pattern.
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.